Skip to content
Catalyst

PapersPMID:35684079

Consumption of Low Dose Fucoxanthin Does Not Prevent Hepatic and Adipose Inflammation and Fibrosis in Mouse Models of Diet-Induced Obesity.

Nutrients2022The record ↗

  1. Finding, insufficient evidenceno difference foundAlanine aminotransferase

No finding here moved its endpoint.

What did not

1 findingHow to read these marks →
  • “No significant differences were present in liver triglyceride and total cholesterol, hepatic fat accumulation, and serum alanine aminotransferase levels between control and FCX-fed mice regardless of whether they were on an HFC or HFS diet.”
    Study
    animal · not in humans
    Dose studied
    0.015% or 0.03% w/w FCX in HFC diet, 12 weeks; 0.01% w/w FCX in HFS diet, 8 weeks
    Population
    C57BL/6J mice, pooled across HFC (high-fat/high-sucrose/high-cholesterol) and HFS (high-fat/high-sucrose) diet-induced obesity models, FCX-supplemented diet vs same diet without FCX

Study record

Design
animal study, in vivo
Species
animal
Population
C57BL/6J mice, two diet-induced obesity (DIO) models: HFC diet (high-fat/high-sucrose/high-cholesterol, NASH-inducing) for 12 weeks, or HFS diet (high-fat/high-sucrose) for 8 weeks
Participants
not reported
Comparator
not stated in the paper / placebo
Duration
not reported
Endpoints measured
6